Cellectar Biosciences, Inc. Resources
News & Media
Investors
Contact
Cellectar Biosciences, Inc.
Home
About
Overview
Partnerships
Management Team
Board of Directors
Technology
Overview
Posters & Publications
Product Pipeline
Overview
CLR 131
Clinical Trials
Overview
For Patients with Relapsed or Refractory Multiple Myeloma
Recruiting
For Children and Adolescents With Relapsed or Refractory Malignant Brain Cancer, Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Not yet recruiting
For Relapsed or Refractory Select B-Cell Malignancies
Recruiting
News & Media
Investors
Contact
Presentations
News & Media
News & Media
Press Releases
Presentations
Events
Corporate Presentation
Feb 7, 2019
